z-logo
open-access-imgOpen Access
Delayed hemodialysis in COVID-19: Case series with literature review
Author(s) -
Michael Connerney,
Yasar Sattar,
Hiba Rauf,
Sahil Mamtani,
Waqas Ullah,
Nara Miriam Michaelson,
Umaima Dhamrah,
Naman Lal,
Sharaad Latchana,
Aaron S. Stern
Publication year - 2021
Publication title -
clinical nephrology - case studies
Language(s) - English
Resource type - Journals
ISSN - 2196-5293
DOI - 10.5414/cncs110240
Subject(s) - covid-19 , hemodialysis , series (stratigraphy) , medicine , intensive care medicine , virology , biology , outbreak , disease , paleontology , infectious disease (medical specialty)
Increased incidence of kidney injury has been seen in patients with COVID-19. However, less is known about COVID-19 susceptibility and outcomes in end-stage renal disease (ESRD) patients on hemodialysis (HD). Reduced angiotensin-converting enzyme 2 (ACE-2) from SARS-CoV-2 binding and increased angiotensin II (Ang-II) activity have been suggested as mechanisms for COVID-19 renal pathophysiology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom